SoftWave Therapy for Neuropathy: What Evidence Should Patients Ask For?

Shockwave research for neuropathy is early and limited. Here's what's been studied and what to ask before starting treatment.

Short answer: research on shockwave therapy for peripheral neuropathy is early — mostly small studies with varied methods. Some report improved symptoms; the evidence is not strong enough to promise results. Neuropathy also needs medical management of its underlying cause, such as diabetes. This article is pending clinician review by Dr. O'Neill.

What Neuropathy Is

Peripheral neuropathy is damage to nerves outside the brain and spinal cord, often causing numbness, tingling, or burning. The NIH National Institute of Neurological Disorders and Stroke explains causes and care.

What Has Been Studied

Search current research on PubMed. Look for randomized controlled trials, sample sizes, and how long patients were followed.

Questions to Ask

• What's causing my neuropathy, and is it being managed?
• What studies support shockwave for my type of neuropathy?
• What outcome will we measure, and when?
• What's the total plan cost?

The Mayo Clinic covers standard treatments. Sudden weakness or loss of sensation needs prompt medical evaluation.

See our neuropathy page and earlier article on shockwave for peripheral neuropathy.

Contact us with questions.